Sigma 1 Receptor and Its Pivotal Role in Neurological Disorders

Overview

Journal ACS Pharmacol Transl Sci

Publisher American Chemical Society

Date 2025 Jan 16

PMID 39816800

Authors

Mustafa M Shokr

Ghada A Badawi

Shimaa M Elshazly

Hala F Zaki

Ahmed F Mohamed

Affiliations

Soon will be listed here.

Abstract

Sigma 1 receptor (S1R) is a multifunctional, ligand-activated protein located in the membranes of the endoplasmic reticulum (ER). It mediates a variety of neurological disorders, including epilepsy, amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease. The wide neuroprotective effects of S1R agonists are achieved by a variety of pro-survival and antiapoptotic S1R-mediated signaling functions. Nonetheless, relatively little is known about the specific molecular mechanisms underlying S1R activity. Many studies on S1R protein have highlighted the importance of maintaining normal cellular homeostasis through its control of calcium and lipid exchange between the ER and mitochondria, ER-stress response, and many other mechanisms. In this review, we will discuss S1R different cellular localization and explain S1R-associated biological activity, such as its localization in the ER-plasma membrane and Mitochondrion-Associated ER Membrane interfaces. While outlining the cellular mechanisms and important binding partners involved in these processes, we also explained how the dysregulation of these pathways contributes to neurodegenerative disorders.

References

Mavlyutov T, Epstein M, Verbny Y, Huerta M, Zaitoun I, Ziskind-Conhaim L . Lack of sigma-1 receptor exacerbates ALS progression in mice. Neuroscience. 2013; 240:129-34. PMC: 3665351. DOI: 10.1016/j.neuroscience.2013.02.035. View

Pabba M, Wong A, Ahlskog N, Hristova E, Biscaro D, Nassrallah W . NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus. J Neurosci. 2014; 34(34):11325-38. PMC: 6615506. DOI: 10.1523/JNEUROSCI.0458-14.2014. View

Mitsuda T, Omi T, Tanimukai H, Sakagami Y, Tagami S, Okochi M . Sigma-1Rs are upregulated via PERK/eIF2α/ATF4 pathway and execute protective function in ER stress. Biochem Biophys Res Commun. 2011; 415(3):519-25. DOI: 10.1016/j.bbrc.2011.10.113. View

Mancuso R, Olivan S, Rando A, Casas C, Osta R, Navarro X . Sigma-1R agonist improves motor function and motoneuron survival in ALS mice. Neurotherapeutics. 2012; 9(4):814-26. PMC: 3480575. DOI: 10.1007/s13311-012-0140-y. View

Laurini E, Col V, Mamolo M, Zampieri D, Posocco P, Fermeglia M . Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor. ACS Med Chem Lett. 2014; 2(11):834-9. PMC: 4017991. DOI: 10.1021/ml2001505. View

Bernard-Marissal N, Medard J, Azzedine H, Chrast R . Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration. Brain. 2015; 138(Pt 4):875-90. DOI: 10.1093/brain/awv008. View

Maurice T, Volle J, Strehaiano M, Crouzier L, Pereira C, Kaloyanov N . Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ receptors. Pharmacol Res. 2019; 144:315-330. DOI: 10.1016/j.phrs.2019.04.026. View

Mamiya T, Noda Y, Noda A, Hiramatsu M, Karasawa K, Kameyama T . Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice. Neuropharmacology. 2000; 39(12):2391-8. DOI: 10.1016/s0028-3908(00)00078-2. View

Kekuda R, Prasad P, Fei Y, Leibach F, Ganapathy V . Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun. 1996; 229(2):553-8. DOI: 10.1006/bbrc.1996.1842. View

10.

Ghasemi N, Razavi S, Nikzad E . Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. Cell J. 2017; 19(1):1-10. PMC: 5241505. DOI: 10.22074/cellj.2016.4867. View

11.

Christ M, Huesmann H, Nagel H, Kern A, Behl C . Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo. Cells. 2019; 8(3). PMC: 6468724. DOI: 10.3390/cells8030211. View

12.

Hetz C, Mollereau B . Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci. 2014; 15(4):233-49. DOI: 10.1038/nrn3689. View

13.

Ricciardi S, Boggio E, Grosso S, Lonetti G, Forlani G, Stefanelli G . Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum Mol Genet. 2011; 20(6):1182-96. DOI: 10.1093/hmg/ddq563. View

14.

Martin P, Reeder T, Sourbron J, de Witte P, Gammaitoni A, Galer B . An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies. Int J Mol Sci. 2021; 22(16). PMC: 8395113. DOI: 10.3390/ijms22168416. View

15.

Ono Y, Tanaka H, Takata M, Nagahara Y, Noda Y, Tsuruma K . SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models. Neurosci Lett. 2013; 559:174-8. DOI: 10.1016/j.neulet.2013.12.005. View

16.

Ramakrishnan N, Schepers M, Luurtsema G, Nyakas C, Elsinga P, Ishiwata K . Cutamesine Overcomes REM Sleep Deprivation-Induced Memory Loss: Relationship to Sigma-1 Receptor Occupancy. Mol Imaging Biol. 2014; 17(3):364-72. DOI: 10.1007/s11307-014-0808-2. View

17.

Hayashi T, Hayashi E, Fujimoto M, Sprong H, Su T . The lifetime of UDP-galactose:ceramide galactosyltransferase is controlled by a distinct endoplasmic reticulum-associated degradation (ERAD) regulated by sigma-1 receptor chaperones. J Biol Chem. 2012; 287(51):43156-69. PMC: 3522309. DOI: 10.1074/jbc.M112.380444. View

18.

Tsai S, Chuang J, Tsai M, Wang X, Xi Z, Hung J . Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope. Proc Natl Acad Sci U S A. 2015; 112(47):E6562-70. PMC: 4664336. DOI: 10.1073/pnas.1518894112. View

19.

Rodriguez-Munoz M, Sanchez-Blazquez P, Garzon J . Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors. Oncotarget. 2018; 9(34):23373-23389. PMC: 5955088. DOI: 10.18632/oncotarget.25169. View

20.

Chahrour M, Jung S, Shaw C, Zhou X, Wong S, Qin J . MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008; 320(5880):1224-9. PMC: 2443785. DOI: 10.1126/science.1153252. View